How Digital R&D Is Transforming API Development and cGMP Scale-Up in India

Vijaya kumar Naganaboina, Head R&D, Wanbury Limited

 Vijaya kumar Naganaboina, Head R&D, Wanbury Limited

During an interaction with Thiruamuthan, Assistant Editor at India Pharma Outlook, Vijaya kumar Naganaboina, Head R&D, Wanbury Limited, discusses how digital R&D is transforming API development and cGMP scale-up in India through AI-enabled process development, predictive modeling and data-driven manufacturing. He highlights the role of process optimization, technology transfer and scientific validation in improving manufacturing consistency and accelerating the development of complex APIs.

Vijaya Kumar Naganaboina, an experienced pharmaceutical R&D leader with over a decade of expertise in API process development, scale-up, and manufacturing. His work spans predictive analytics, cGMP manufacturing, technology transfer and regulatory submissions, with a focus on digitalization and improving process efficiency.

In API process development, how can AI-enabled Design of Experiments (DoE) using machine learning identify complex relationships between reaction variables and critical process parameters?

In many Indian API companies, Design of Experiments (DoE) is still largely approached through the traditional one-factor-at-a-time methodology. However, parameters such as temperature, base equivalents, addition rate and moisture content are interdependent, and their interactions cannot be adequately captured by a simple quadratic model. In simple words:

  • Decision Tree: A sequence of yes-or-no decisions, similar to a structured batch troubleshooting process. For example, is the temperature above 60°C? Is the moisture content above 0.5%? Based on these conditions, the model predicts whether impurity levels are likely to be high. Each decision tree generates an individual prediction.

  • Random forest: one prediction can go wrong, like the opinion of one chemist. So it makes hundreds of trees on slightly different portions of data and takes the average of hundreds of predictions.

  • XGBoost: first tree predicts, second tree corrects its error, third corrects remaining error, hundreds of times. Like a student correcting mistakes after every test.

  • Gaussian Process Regression (GPR): gives a prediction and also "how sure I am", so the next experiment is planned where the model is least sure.

These models capture non-linear relationships and interaction effects, while even failed experiments help identify conditions to avoid. In one polymorph-related challenge, GPR-guided experiments helped us understand the combined effects of seeding temperature and cooling rate. Feature importance also shows which parameter is driving the result, a good start for criticality assessment.

However, with only 20–30 experiments, models can easily overfit, memorizing data rather than identifying meaningful patterns. Both modeling and mechanistic understanding are essential for gaining QA and regulatory acceptance.

AI models can capture non-linear relationships between process parameters, but mechanistic understanding remains essential to prevent overfitting and secure quality assurance and regulatory acceptance

When scaling an API process from laboratory to commercial production, how can predictive models account for differences in mixing, heat transfer and reaction kinetics?

Scale-up is like cooking biryani for four people at home and then preparing it for 400 at a wedding. The recipe remains the same, but the vessel, heat and stirring conditions change. In a 6 KL reactor, mixing times can differ significantly from those in the lab, while dosing can take hours instead of minutes.

For the first scale-up, there is no plant history available. Therefore, the model is built using lab data, reaction kinetics, heat of reaction from calorimetry and plant equipment characterization, including jacket heat transfer and kLa for hydrogenation.

Even before the first batch, the model helps determine whether the reaction is kinetics- or heat-removal-controlled and establish a safe dosing time. Work-up is also considered, as a significant part of the yield gap can arise from filtration, washing and mother liquor losses. Model accuracy is assessed using RMSE (Root Mean Square Error), which measures the average prediction error. An RMSE of 2 indicates that the model's prediction is off by approximately 2% in yield.

However, prediction alone cannot solve scale-up challenges. It tells us what is likely to happen, such as the plant achieving 78% yield when the lab achieves 88%, but not what action to take. Dosing time, cooling rate and equipment selection can all involve competing requirements. This is where the predict-then-optimize approach becomes important.

The optimizer searches inside the model for best settings within constraints like jacket delta T, safe dosing time and impurity specification, with Mixed Integer Linear Programming (MILP) handling yes/no equipment choices. It also shows which constraint impacts most if heat removal stops faster dosing, the answer is colder brine, not one more lab trial.

Prediction without optimization is like having a weather forecast without deciding whether to carry an umbrella or wear a raincoat. Both predictive modeling and prescriptive optimization are essential.

During API technology transfer, how can digital process data and development knowledge help manufacturing teams reproduce critical process parameters and impurity profiles at commercial scale?

The biggest challenge in tech transfer is not parameters; it is knowledge behind them. The development report tells "what" but rarely "why," and the why walks out of the company with the chemist.

First, a knowledge package linking each parameter to CQA, with impurity fate and purge map, so when the plant sees a new impurity, you trace in hours which step should remove it. Second, plant temperature, dosing and pH profile overlaid on pilot "golden batch", so deviation is visible before out of specification (OOS). Third, capture small things nobody writes in the tech pack - hold times, water quality, and order of addition. More than once, I saw ROI failure traced to lab versus plant water.

How can Process Analytical Technology (PAT) data support continued process verification by identifying process drift before it affects critical quality attributes in API manufacturing?

Traditional Continued Process Verification (CPV) is trending release results once a year, like checking sugar once a year. By then, many batches are made.

Process Analytical Technology (PAT) provides real-time process visibility through tools such as FTIR or Raman for endpoint, FBRM for crystallization and NIR for Loss on Drying (LOD). Combined with Principal Component Analysis (PCA), which squeezes 30 related trends into two or three charts, it helps identify process drift before any individual parameter crosses its limit.

For example, reaction time may gradually increase from batch to batch, with each batch remaining within the acceptable range. However, the trend may indicate changes in raw material quality or jacket fouling. This allows corrective action before Critical Quality Attributes (CQAs) are affected.

No need for full PAT to start. DCS/SCADA data is already stored, and nobody is looking at it.

What scientific and validation evidence should API manufacturers establish before using AI-based predictive models to guide process development and GMP manufacturing decisions?

Start with intended use and risk. A model suggesting the next laboratory experiment is different from one determining a batch endpoint. The FDA draft guidance refers to the "context of use", while the EU draft Annex 22 permits only static locked models for critical GMP applications.

Data must comply with ALCOA+ principles and cover real process variability. Garbage in, gospel out: an incorrect answer can come with a very confident appearance.

Validation should be performed using independent batches, with acceptance criteria defined in advance (for example, RMSE for yield NMT 2%). Models should never be used outside their trained range, and their predictions must make chemical sense.

Retraining must go through change control, with model drift monitored and a human involved in every GMP decision. Run the model in "shadow mode" for a few campaigns before relying on its predictions.

Looking ahead to 2030, where do you expect AI-enabled process development and predictive modeling to make the greatest difference in India's ability to develop and manufacture complex APIs?

For complex APIs, India's key gaps are speed and right-first-time execution. This is where AI can make the biggest difference. Retrosynthesis combined with patent landscape analysis can reduce route scouting from months to weeks. Other promising applications include polymorph prediction, where many programs face challenges during validation, flow chemistry for hazardous reactions under ICH Q13, and predict-then-optimize approaches to bridge the lab-to-plant gap.

The main challenges remain data foundation and skilled talent. AI will not replace process chemists, but chemists who use AI will certainly have an advantage over those who do not.

on the deck

Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest

Related Articles

© 2026 India Pharma Outlook. All Rights Reserved.